ArticleInternational ophthalmology2026
The effect of mitomycin-C on 3 snip punctoplasty.
Article in International ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo investigate the effects of Mitomycin-C (MMC) use and duration of application on surgical outcomes in patients who underwent 3 snip punctoplasty for epiphora. MATERIAL AND
methodsDemographic characteristics, follow-up period, nasolacrimal passage patency, degree of punctum stenosis (graded between 0 and 5), presence of epiphora and accompanying diseases of the cases who applied with epiphora complaint between June 2015 and May 2024 were evaluated retrospectively. 3 snip punctoplasty was applied to all cases.The cases were divided into 3 groups. Group 1: 3 snip without MMC, group 2: 3 snip with 0.3% MMC for 1 min, group 3: 3 snip with 0.3% MMC for 2 min.
resultsIn this study, 180 eyes of a total of 90 cases were examined. 50 (55.5%) of the cases were female and 40 (44.5%) were male. The average age of the cases was 42.2 ± 3.8 (35-68).The average follow-up period was 6.2 ± 1.5 (6-8) months. In 2 of the cases (2.2%), the postoperative nasolacrimal lavage was closed at the punctum level. Preoperative punctal stenosis grade was 2 in 60 cases (66.6%) and 1 in 30 cases (33.4%). There were no postoperative epiphora complaints in 24 (80%) patients in group 1, 27 (90%) patients in group 2, and 28 (93.3%) patients in group 3. The difference between groups 1 and 2 was statistically significant (p < 0.05).The difference between groups 2 and 3 was not statistically significant (p > 0.05). Postoperative corneal epithelial defect development was observed in 1 of the cases.
conclusions3 snip surgery is a successful method in the treatment of punctal stenosis, and the use of MMC may increase success. Increasing the duration of MMC application did not improve surgical success.
Indexed as
Identifiers
41575659What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.